Profund Advisors LLC Grifols Sa Transaction History

Profund Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$16.86 - $19.67 $306,481 - $357,561	-18,178 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$15.4 - $20.16 $51,913 - $67,959	-3,371 Reduced 15.64%	18,178 $315,000
Q2 2020 Aug 03, 2020	BUY	$18.24 - $21.45 $71,227 - $83,762	3,905 Added 22.13%	21,549 $393,000
Q1 2020 May 15, 2020	SELL	$16.28 - $25.63 $88,025 - $138,581	-5,407 Reduced 23.46%	17,644 $355,000
Q4 2019 Feb 18, 2020	SELL	$19.57 - $23.52 $35,010 - $42,077	-1,789 Reduced 7.2%	23,051 $537,000
Q3 2019 Nov 12, 2019	SELL	$19.85 - $22.76 $65,842 - $75,494	-3,317 Reduced 11.78%	24,840 $498,000
Q2 2019 Aug 13, 2019	BUY	$17.59 - $21.1 $7,053 - $8,461	401 Added 1.44%	28,157 $594,000
Q1 2019 May 15, 2019	BUY	$18.01 - $20.11 $81,819 - $91,359	4,543 Added 19.57%	27,756 $558,000
Q4 2018 Feb 14, 2019	BUY	$17.44 - $21.53 $404,834 - $499,775	23,213 New	23,213 $426,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Profund Advisors LLC with notifications on news.